Teladoc Health SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 28, 2026, 4:04 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedTeladoc Health Q3 2026 revenue of $605.1 million beats $590.5 million consensus and EPS of -$0.15 beats -$0.19, but FY2026 EPS guidance midpoint of -$0.85 trails -$0.79 consensus
SCHEDULE 13GOct. 8, 2026, 2:25 p.m. ETView on SEC.gov
4Oct. 5, 2026, 4:05 p.m. ETView on SEC.gov
8-KSept. 25, 2026, 8:30 a.m. ETView on SEC.gov
Departure/appointment of directors or officers
4Sept. 14, 2026, 4:05 p.m. ETView on SEC.gov
4Sept. 3, 2026, 4:06 p.m. ETView on SEC.gov
4Sept. 3, 2026, 4:05 p.m. ETView on SEC.gov
4Sept. 3, 2026, 4:05 p.m. ETView on SEC.gov
4Sept. 3, 2026, 4:05 p.m. ETView on SEC.gov
4Sept. 3, 2026, 4:05 p.m. ETView on SEC.gov
4Sept. 3, 2026, 4:05 p.m. ETView on SEC.gov
4Sept. 1, 2026, 5:15 p.m. ETView on SEC.gov
8-KAug. 31, 2026, 4:35 p.m. ETView on SEC.gov
Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits
8-KAug. 13, 2026, 4:05 p.m. ETView on SEC.gov
Departure/appointment of directors or officers
4Aug. 4, 2026, 4:05 p.m. ETView on SEC.gov
8-KAug. 3, 2026, 4:31 p.m. ETView on SEC.gov
Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits
10-QJuly 30, 2026, 9:54 a.m. ETView on SEC.gov
8-KJuly 29, 2026, 4:05 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits